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            ABSTRACT 
Background:  Minimal hepatic encephalopathy (MHE) occurs in patients with 
cirrhosis of liver but with only subtle alterations in cognition and psychomotor 
functions. The aim of the study is to assess the usefulness of Psychometric tests 
and Critical Flicker Frequency Test (CFT) in  detecting  MHE . 
Methods: We examined 100 patients diagnosed as cirrhosis with Psychometric 
tests - Number connection tests –A and B(NCT-A &B), Line Tracing Test(LTT) , 
Digit Symbol Test(DST), Serial Dotting Test(SDT) and Critical Flicker Frequency 
Test and compared the above tests  with 50 normal people as controls. 
Results: The sex distribution showed Male preponderance with 76% males in the 
study group and 64 % in the control group. Mean age of presentation is 40 years. 
Psychometric tests showed abnormal results with NCT- A in 17%, NCT-B in 60%, 
DST in 67%, LTT in 74%, DT in 70% and CFF in 73% among the study group but 
no significant results among the control group. Both the Psychometric tests 
(p=0.000) and   Critical Flicker Frequency Test (p=0.000) were useful in detecting 
cases of Minimal Hepatic Encephalopathy in patients with cirrhosis. 
 
Conclusion: Both the Psychometric tests and CFF tests were effective in 
diagnosing Minimal hepatic encephalopathy. Psychometric tests have subjective 
variations  with  consumption of more time while CFF Test is more objective in 
nature requiring no educational qualifications for undergoing and interpretation of 
the light stimulus and is  highly reproducible. Hence we recommend CFF test as 
screening procedure in Out Patient Department to detect MHE earlier . 
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INTRODUCTION 
Hepatic encephalopathy (HE) is a potentially reversible, 
metabolically caused disturbance of central nervous system function that 
occurs in patients with acute or chronic liver disease. It encompasses a 
board spectrum of neurological symptoms of varying severity and is 
classified according to clinical symptoms. Minimal hepatic encephalopathy 
(MHE), previously known as subclinical or latent hepatic encephalopathy, 
is at the beginning of this spectrum. MHE has a high prevalence among 
patients with liver cirrhosis (22% to 74%).   
It is defined as HE without symptoms on clinical/neurological 
examination, but with deficits in some cognitive areas that can only be 
measured by neuropsychometric testing and critical flicker frequency test. 
The areas with impairments are attention, visuospatial perception, speed of 
information processing, especially in the psychomotor area, fine motor 
skills, and short-term memory leading to impaired quality of life and 
ability to work-associated with driving errors, accidents and further 
deterioration into overt encephalopathy and thereby with increased 
mortality. In our study, we study the effectiveness of Psychometric tests 
and Critical flicker frequency test in detecting minimal hepatic 
encephalopathy earlier in patients with cirrhosis. 
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AIMS AND OBJECTIVES 
 To study the usefulness of psychometric tests and critical flicker in 
diagnosing Minimal hepatic encephalopathy in patients diagnosed as 
cirrhosis . 
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REVIEW OF LITERATURE 
Hepatic encephalopathy is (HE) defined as serious  but  reversible  
disturbances in the functions of central nervous system due to liver failure 
manifested as an alteration in cognitive function and mental status. It is 
one of the most common complications of cirrhosis having detrimental 
effects on leading a quality of life and on patient’s survival. The 
development of HE in acute liver injury is considered as a prerequisite 
for a diagnosis of  Fulminant  hepatic failure . The underlying mechanism 
for the development of HE has been reported as escape of toxins derived 
from the gut into the systemic circulation as they are not metabolized by 
the liver due to shunting of blood  through  collaterals  and  also due to 
reduction in functioning liver tissue mass.   
 
CLASSIFICATION OF HEPATIC ENCEPHALOPATY 
Overt hepatic encephalopathy develops as a clinically apparent    
syndrome with  varied manifestations consisting of motor and psychiatric  
disorders and develop over days to months(1). 
 
 Hepatic encephalopathy  develops in patients with chronic liver 
disorders who had been normal and stable over hours  to days.  Such a 
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development of episodic and overt hepatic encephalopathy may arise  in 
those patients frequently and intermittently(2). The patients may recover to 
normal with intervening episodes of   encephalopathy. Sometimes few 
other patients may have persistence of neuropsychiatric abnormalities and 
remaining stable over a period of time.  
 
Thus there  exist two types of overt encephalopathy with some 
common   clinical features. There may be varied symptoms as minimal 
alterations in their personality , disturbances in cognitive functions to deep 
state of coma. They may have behavioral changes and irritability due to 
changes in  personality.  
 
            The mental function may be affected minimal to severe confusion 
and further deterioration may lead to coma. They may have constructional 
apraxia and alterations in the pattern of sleep is also seen . Sleepiness 
during day time and few other disturbances in the pattern of sleep during 
the night are noticed(3). 
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              Some patients exhibit foetor hepaticus in which there occurs a 
musty , sour and faeculent smell like because of the Mercaptans(4).Neither 
its presence could correspond to the duration and severity of  the hepatic 
encephalopathy nor the absence of mercaptans precludes  the diagnosis. 
 
         Alterations in the motor system include that of disturbances in speech 
, rigidity and tremors (5,6) as   extrapyramidal features and  pyramidal 
features as exaggerated deep tendon reflexes  with increased tone of the 
muscles and  Positive  Babinski sign(7,8) . The flapping tremors  also 
known as Asterixis is noticed which is not specific for hepatic 
encephalopathy as also seen in respiratory system failure , renal failure , 
cardiac failure , toxicity of phenytoin and electrolyte disturbances as in 
hypomagnesemia. 
  
Episodic hepatic encephalopathy 
            Episodic type of hepatic encephalopathy develops in patients who 
had stable clinical status with majority of them with an identifiable 
precipitating underlying  cause .  
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  Precipitating causes lead to hepatic encephalopathy by various 
mechanisms as by  
         1) Rise in Nitrogenous end products,  
 2) Affecting and causing depression of functions of brain and liver. 
The patients with overt hepatic encephalopathy  may recover from 
encephalopathy with the visibly  improving clinical condition earlier than 
improvements appearing  in Electroencephalogram and in Psychometric 
tests(24).  
              Still there remains  some impairments affecting those of cognitive 
,  neuropsychiatric functions commonly encountered with either through 
sugery or larger spontaneously created portosystemic shunts, and with 
sever decompensation of the underlying chronic liver disease  
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PRECIPITATING CAUSES OF HEPATIC ENCEPHALOPATHY 
           
Persistent hepatic encephalopathy 
Few patients with chronic liver disorders will exhibit persistence  of 
features of encephalopathy but with stable clinical status  and often with 
significant portosystemic shunt .  
           There may not be alterations in the level of consciousness but  
increased  severity of these  pre existing symptoms . In addition, there may 
be marked rigidity, unintentional fine tremors, with a shuffling gait and 
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speech of staccato type . Its diagnosis is often missed as there may not be 
clear presence of biochemical alterations and other  clinical  features .  
  
Minimal hepatic encephalopathy 
This group consists of patients with cirrhosis and normal clinical 
status but still with impairment of cognition and motor functions (12, 27) . 
Minimal hepatic encephalopathy severely affects the complex tasks (30, 
31) as in the case of driving skills and impairs the quality of life (28, 29) 
and needs to be diagnosed earlier without which it may progress to Overt 
type of encephalopathy (32, 33, 34). 
 Pathogenesis   
           The pathogenesis in HE is highly  controversial  and  several 
theories have been put forth in the past. Two most essential factors namely 
as failure of the liver and shunting of portosystemic circulation have been 
identified for the development of Hepatic  encephalopathy . There are 
some instances wherein shunting of portosystemic circulation with the 
preservation of liver functions does not result in the development of 
hepatic encephalopathy.  
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       There are several  changes  associated with the development of 
Hepatic encephalopathy  
 
Neurotoxins derived from the intestines 
              Various neurotoxins have been found to be derived from the 
intestines and are associated with the development of Hepatic 
encephalopathy amongst which Ammonia is considered to play a key role.  
              Synthesis of   Ammonia takes place  
                       1) From the  proteins contained in the diet ,  
                      2) By  the action of colonic bacteria , 
                      3) By the deamination action of Glutaminase on Glutamine . 
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The ammonia thus formed are absorbed and attains higher 
concentrations in the Portal venous blood. The liver cells absorb ammonia 
and convert it to urea through the  reactions  in  Urea cycle. 
 
The level of ammonia in the blood is raised in the following 
instances.  
 
a) Due  to the increased flow of blood through the splanchnic 
circulation secondary to portal hypertension favouring the increased 
absorption of ammonia 
 
          b) Due to decrease in liver mass with retained functions . 
 
          c) Increased colonization of intestines with urea splitting enzyme 
Urease leading to increased synthesis of ammonia in the bowel . 
 
           d) Due to  reduced mass of muscle in patients with cirrhosis 
resulting in reduction of metabolism of ammonia in the muscle . 
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       The uptake of ammonia by the brain is enhanced in patients with 
cirrhosis (35). Notably urea cycle does not take place in the brain . 
Ammonia is found to have detrimental effects on the astrocytes with 
marked predilection for Basal ganglia, cerebellum and cortex of the 
cerebrum .The neurons located in the cortex of the cerebrum are also 
significantly(36) . 
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             There is a poor correlation between the levels of ammonia in the 
blood and the severity of the impairment in cognitive and motor functions 
.Few more neurotoxins found to be in association with the development of 
hepatic encephalopathy are 
      a) Mercaptans 
       b) fatty acids with short and medium chains 
       c) Indoles  
       d) Phenols 
 The above said toxins are said to exhibit their toxicity on the 
functions of cortical neurons either directly or  with synergistic action 
along with ammonia leading to the development of hepatic 
encephalopathy.  
 Homeostasis of Brain water 
            Entry of ammonia into the central nervous system leading to 
increased concentrations of glutamine which is osmotically active thereby 
causing the swelling of Astrocytes. To neutralize the increased 
concentrations of osmotically active glutamine,   astrocytes drive away few 
other substances which are osmotically active .Despite the above , cerebral 
edema of  low grade develops  which had been demonstrated with the help 
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of Diffusion transfer  Magnetic  Resonance techniques of imaging (37,38) 
and Cerebral Magnetization techniques. There also exists a fair amount  of  
correlation  between the degree of severity of HE and the changes noticed 
during Cerebral 1H-Magnetic Resonance  Spectroscopy(39,40) . A small 
increase in the water content of   astrocyte although would not rise the 
intracranial tension but will impair the functions of the brain.   Along with 
Ammonia , few other contributing factors like  Benzodiazepines , 
hyponatremia  and other inflammatory mediators also result in  cerebral 
oedema of low grade . 
 
Oxidative/ nitrosative stress [41] 
Available evidences from studies  conducted  in experimental 
animal models substantiates the role of  oxidative/ nitrosative stress in the 
development  of hepatic encephalopathy. When there is a loss of balance 
between  the  generation of Oxygen derived  free radicles , Nitric oxide 
free radicles  and the antioxidant system in the form of scavenging the free 
radicles , there occurs the  Oxidative/ nitrosative stress .If the free radicles 
generated  in excess lead to cellular damage and its death . 
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Various   inflammatory mediators ,  swelling of astrocytes secondary 
to osmotic changes , Benzodiazepines and ammonia lead to generation of 
Oxygen derived  free radicles and Nitric oxide species through N  methyl d  
aspartate glutamate receptors by yet unidentified mechanism  
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There appears an inter relationship between oxidative  stress , 
astrocyte swelling, and  activation  of NMDA receptor. Swelling of 
astrocytes leads  to  oxidative stress via NMDA receptor activation  and 
Calcium ions  dependent  steps  which  results in further  swelling of 
astrocytes in a viscious cycle.  
Dysfunction of Astrocytes    
Swelling  of  astrocytes  and  oxidative  stress  impair the functions 
of astrocytes in patients with hepatic encephalopathy.  The  tyrosine 
residues in the  proteins  of  the astrocytes  undergo covalent modification  
and nitration of tyrosine residues takes place. This type of modification 
impairs the function of the protein and also affect the  signal  transduction  
of the astrocytes adjacent to the blood brain barrier and hence the transport 
of substrate  inside the astrocytes  .The reaction of nitration of proteins 
may not  involve all proteins thereby  permeability of the blood brain 
barrier getting affected selectively .  
 
The free radicles derived from oxygen causes oxidation of RNA 
affecting the  processes of protein synthesis resulting in the  formation of  
unstable and defective proteins .Consequently , receptors for 
neurotransmitters are synthesized and assembled  defectively impairing the 
neurotransmission. Zinc is  mobilized from proteins  due to nitric oxide 
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derived free radicles  and zinc ions impair the functions of several enzymes 
.Zinc also reduces  the uptake of Glutamate and enhances the GABAergic 
neurotransmission .  
 
The functions of Astrocytes are directly  impaired  by Ammonia by 
resulting in the  alterations  in  the transport, metabolism of 
neurotransmitters  [42] , transduction of intra-cellular signals , and genetic  
expression . The above  changes in functions of astrocytes  eventually 
culminates in  the  impairment of plasticity of the synapse, slowing of 
oscillatory neuronal activity and  disruption of glioneuronal 
communication .     
       
Alterations in cerebral neurotransmission  
          Several neurotransmitters  are affected  in  these patients with a gain 
of upper hand for the inhibitory system over the excitatory system due to 
an increase in the tone of GABAergic system . 
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Glutamate 
The chief excitatory neurotransmitter in the central nervous system 
is Glutamate  and is produced in the  presynaptic  neurons and contained in 
the storage vesicles. 
 
             Following  its release into the synaptic cleft ,  reuptake of 
glutamate  into the astrocytes  occur where it  combines with ammonia  to 
yield glutamine   in the presence of  an enzyme Glutamine synthetase.  
 
                Subsequently , transportation of glutamine  to the presynaptic 
nerve terminals is carried out and converted back to glutamate. Glutamate 
levels in the brain are reduced in these patients as it is  utilized  in its 
conversion to glutamine with the availability of excess ammonia. 
Paradoxically the levels of glutamate in the CSF and ECF are raised due to 
release from the astrocytes following  its  swelling  and defective reuptake 
. Ammonia  plays  a role in the reduction of receptors for glutamate  over 
the membranes of neurons and astrocytes (43,44). 
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γ - Aminobutyric acid and the neurosteroid system(45)  
The main neurotransmitter with inhibitory function in the  central 
nervous system is Gamma  Amino butyric acid . The receptor for GABA 
consists of a complex structure  with  regions for binding with 
Barbiturates, Neurosteroids and Benzodiazepines which after binding 
causes  inward flow of chloride ions . Consequently  there occurs 
hyperpolarization and further inhibition . 
 
It has been found out that GABA-ergic activity is increased in 
patients with hepatic encephalopathy . Several compounds have been 
reported with neurotoxicity  that include Neurosteroids , ligands  with 
action similar to Benzodiazepine  and Ammonia . They were found to have 
modulatory effects on the function of GABA receptor .  There are few 
Neurosteroids thought to be produced in the astrocytes of the central 
nervous system that include Allopregnanolone  which causes increased  
GABAergic  activity in patients with hepatic encephalopathy . 
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 It has been found out that in the brains of patients died due to 
hepatic coma levels of allopregnanolone is  raised . Neurosteroids have 
been found to potentiate the toxic effects of Ammonia on the central 
nervous system by their modulatory effects on the GABA receptor thereby 
increasing inhibitory  action.  
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They are also produced in the gonads, adrenals and kidneys  with 
their levels raised  in patients with failure of the  Hepatic functions 
.Chemically , neurosteroids are lipid soluble  reflecting their ability to 
cross the BBB and resulting in the effects of inhibition . The levels of the 
precursors of neurosteroids  are also elevated in liver failure.   
 
They   also impair the effects of  Glycine ,NMDA , Opioids and 5-
hydroxy tryptamine in patients affected with  hepatic failure . 
Neurosteroids   can   affect  the  processes of  Transcription thereby 
impairing the  coding for the synthesis of various receptors and other 
proteins in the central nervous system .  
 
 The critical role of GABA  system  in the development of 
encephalopathy  is  also proven by the raised sensitivity to 
Benzodiazepines (23) and over the fact that few patients got  some 
improvement on treating them with Flumazenil having antagonistic  effects 
on receptors of Benzodiazepine(46) .   
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Serotonin 
          Serotonin (5 - hydroxytryptamine;5 - HT) is  a neurotransmitter  
with exerting their actions  for the maintenance of consciousness  and the 
cortical arousal. The enzyme MonoAmine Oxidase A  [MAO-A] is 
involved in the metabolism of Serotonin (47) and its concentration is 
increased in the blood accompanied with a raise in its  receptors(49) in 
these patients . 
 
               Also, the levels of its metabolites as 5-OH Indole acetic acid  is 
raised in the brain tissues . Antagonist of serotonin namely Ketanserin is 
used for  the treatment of portal hypertension(50) and its utility in this 
condition confirms the role played by the Serotonin in the development of 
hepatic encephalopathy .  
 
Dopamine 
               Another neurotransmitter  namely  Dopamine  serves  the 
functions of attention , mood,  learning,  behavior ,  motivation, and 
cognition voluntary movement . The enzyme involved in the clearance of 
Dopamine namely MonoAmineOxidase (51) is raised along with the 
byproducts like Homovanillic acid levels (48)  in the brain tissue .Contrary 
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to these , Dopamine receptors are reduced (52) and further resulting in its  
depletion leads to  features characteristic of Parkinsonism .    
The toxicity of Manganese is characterized by its accumulation in 
the globus pallidus and the caudate nucleus revealed in the Magnetic 
Resonance Imaging .Such patients exhibit features of Extra-pyramidal 
disorders and hence those features  of Extra-pyramidal disorders are 
experienced by these patients .Also these patients get improvement 
following the treatment with Bromocriptine and other agonists of  the  
Dopaminergic system confirming the role of Dopamine and its system in  
hepatic encephalopathy . 
       Few other systems of neurotransmitter like Opioids system and 
Histamine neurotransmitter systems have also been reported to be altered 
in these patients . 
There are some reports indicating the involvement of Adenosine and 
AcetylCholine  systems with a decrease in the AcetylCholine  due to raised 
functions of its metabolizing enzyme AcetylCholine Esterase .  
 Acetylcholine acts through 1) Nicotinic receptors causing excitation 
while through 2) muscarinic  receptors   leading to  the inhibition of  
transmission of GABA system .  
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             The density of receptors for Nicotinic system is reduced and that 
of binding affinity of ACh for muscarinic receptors is also reduced   
thereby an increased activity of GABA egic inhibition . One of the 
reversible AntiCholine Esterase Antagonist as Rivastigmine is effective in   
the treatment of these patients pointing to the involvement of Ach  system .  
 
              Further,   the   adenosine system is also affected and alterd   
thereby impairing the balance between excitatory and inhibitory  systems 
of neurotransmission . 
 
Inflammation  and   infection(67)  
                 There  will be immunocompromised state in cirrhotic patients 
with diminished capability of Macrophages and Neutrophils to eliminate 
the infectious pathogens .There  occurs endotoxemia for prolonged 
duration of time secondary to the transmigration of the bacteria  and poses 
risk for infection .Such infections can lead to the development of   hepatic 
encephalopathy .There occurs a combination of infection  which is 
developed by an infectious pathogen  and inflammation – a complex 
response initiated by the cells and tissues in response to an injurious 
stimuli leading to the formation of inflammatory mediators. Both   the  
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inflammation  and  infection  can occur together resulting in the tissue 
damage .  
 
 Two essential parts of   Blood   brain barrier as Endothelial cells and 
astrocytes   participate in the systemic inflammation with the release of 
several inflammatory mediators and also affecting  the neurotransmitter 
systems .  
 
There occurs defects in the functions of Neutrophils caused by 
ammonia and subsequently   with the generation of Oxygen derived free 
radicles . These free radicles  lead to the cellular injury and inflammation 
with the resultant ineffective Neutrophils in dealing with the infectious 
organism and deterioration of the effects of ammonia over the brain .  
 
 Therefore ,the participation of  neutrophil and the endothelial 
interaction in the microcirculation of the brain  leads to the migration of 
the Neutrophils across the blood brain barrier and then results in the 
release of inflammatory mediators and eventually free radicle induced 
swelling and damage of the Astrocytes .These above said processes are 
facilitated with increased Ammonia levels and endotoxemia of chronic 
duration causing further deterioration and damage to the  Astrocytes and 
neuronal tissues .The concept of giving Probiotics reducing the incidence 
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of intestinal translocation of gut bacteria strengthens the role of  infection 
and further inflammation in the precipitation of encephalopathy . 
 
An  unified hypothesis for hepatic encephalopathy  
The bypass of Ammonia leaves  it  detoxified , gains access into the 
systemic circulation and on reaching the brain exerts its neurotoxic effects 
on the brain tissues  wherein causes swelling of Astrocytes through 
glutamine and glutamate  
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reactions .Then it causes cerebral edema of low grade in severity . 
Swelling of the Astrocytes results in the generation of free radicles derived 
from Oxygen and Nitric oxide and further altering the homeostasis of 
water in the brain tissues due to toxicity of  Ammonia . In addition to the 
above,  there occurs  impairment of signal transduction intracellularly, 
altered genetic expressions , covalent modification of proteins and nuclear 
material  and impaired neurotransmission .These further impairs the 
communication between the neural tissues and affecting the plasticity of 
the synapse . Constipation , GI bleeding and increased dietary intake of 
protein can lead to the precipitation of encephalopathy due to associated  
raised levels of Ammonia .Besides the above  proinflammatory mediators , 
Benzodiazepines and reduction in the serum Sodium levels have also been 
implicated in the development of encephalopathy. 
Cirrhosis of liver 
 Hepatic encephalopathy is develops in Cirrhosis of liver . Cirrhosis 
of liver, irrespective of the underlying cause, is characterized by the 
presence of fibrosis along with regenerating nodules thereby leading to the 
distortion of architecture of hepatocellular  structure . Laennec  coined  the 
Greek term,  Schirrus referring to tawny or orange coloured liver surface 
seen at the time of autopsy.  Previously there was a thought that cirrhosis is 
irreversible but now it  is considered  that once the underlying  cause or 
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insult is removed  then fibrosis of liver  becomes reversible. There have 
been various causes enumerated to cause cirrhosis as in the following table  
classified based on their etiology.       
      
Causes of Cirrhosis :                      
  1)Alcoholism              
 2)Chronic viral hepatitis        
   Hepatits B        
   Hepatitis C       
 3)Non alcoholic steatohepatitis       
 4)Autoimmune hepatitis          
 5)Biliary cirrhosis           
   Primary Biliary Cirrhosis     
   Primary sclerosing cholangitis      
   Autoimmune cholangiopathy     
 6) Metabolic causes               
   Haemochromatosis     
   Wilson’s disease       
   Cystic Fibrosis          
   Alpha-1 antiyrypsin deficiency     
   Galactosemia       
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   Tyrosinosis        
   Type IV Glycogen storage disorder     
   Hereditary Fructose Intolerance    
 7)Hepatic venous outflow obstruction     
   Budd chiari syndrome      
   Veno-occlusive  disease     
 8)  Drugs and Toxins – Amiodarone , Methotrexate ,  
 9)  Schistosomiasis        
 10) Indian childhood cirrhosis          
 11)  Right Heart failure – chronic      
 12)  Cryptogenic cirrhosis       
           
 Liver consists of several hepatic lobules of one cell thickness  with 
the intervening sinusoids .The fenestrated  endothelial cells line a 
basement membrane which separates the sinusoidal lumen from the space 
of  Disse which separates the hepatocytes from the sinusoidal endothelium.   
 
             In the space of Disse , Stellate  cells lie with the attachment  to the 
basement membrane. Kupffer cells are seen adhered on  to the  surface of 
the fenestrated endothelium facing the sinusoids.  
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                 The  movement  of  the nutrients  and other molecules  occur  by 
passing through the fenestrae of the wall of the  sinusoid and across the 
Space of Disse  thereby reaching the  basal surface of the hepatocytes . 
Such a   transport of nutrient molecules are deranged  by changes in the 
extracellular matrix and the cells subsequent to  liver injuries .  
   
 
   Fig.A      Fig.B  
 A)Normal relationship between cells  and matrix  between 
hepatocytes and sinusoids  B) After injury of liver     
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 Normally in the  liver , the  connective tissue matrix contains Non 
fibrillary collagen of type IV , Proteoglycans as Heparan sulphate and 
Glycoproteins as Fibronectin , Laminin  which  all  constitute  the Low 
density basement membrane in the space  of  Disse. They form a  lattice  
like matrix providing the   cellular support and molecular signals  essential  
for carrying out the  differentiated functions of cells and thus allowing   the 
transport of solutes and growth factors to take place   across  the  basement 
membrane between hepatocytes  and  sinusoid . 
 
After the liver  injury has occurred ,  extracellular matrix  increases 
to 3to 8 folds and is now  composed mostly of  high  density interstitial 
fibril - forming collagens as  types I and III, rather than type IV in addition 
to  hyaluronic acid ,  fibronectin, and other matrix  proteoglycans.  
 
Besides the above changes ,  endothelial cell fenestrations and 
hepatocyte  microvilli  are lost  resulting in   ‘ capillarization ’ of sinusoids, 
and thereby  impeding  the metabolic exchange between the hepatocytes 
and the   blood .Subsequently , collagen of type 1 fibers  accumulates 
gradually due to decreased degradation and increased synthesis considered 
as the hallmark of  fibrosis.       
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              The principal  cell  involved in fibrosis  is the Stellate cells 
present within the Space of  Disse . It is also known as Ito cell , Pericyte , 
Fat storing cell . Ito cells remain in direct contact with endothelial cells, 
hepatocytes and   inflammatory   cells . Normally, stellate   cells  have 
intracellular droplets comprised of   vitamin  A. It contains  40 – 70%  of  
the  total body stores of retinoids in the liver.      
The stellate cells   produces predominantly type IV collagen during  
the quiescent stage  which is the  characteristic type of collagen  found in  
a basement membrane normally .  It undergoes a few  changes  following 
an injury  ,  in  its phenotype  referred to as ‘ activation ’ characterized  by 
cellular proliferation, increased  contractility with expression of smooth 
muscle specific α – actin , secretion of  proteinases  degrading  the  matrix  
and  synthesis of collagen of type I being  the characteristic feature of 
cirrhosis of liver .   
 
The activation of stellate cells  is considered to be an important step  
in the development of   hepatic  fibrosis  and it takes place  in  two steps  as   
A) Initiation   
B) Perpetuation 
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 During the Initiation phase,   early events take place  as  rapid  
changes in phenotype of the stellate cell  and  genetic expression thereby 
enhancing  the responses chemokines , cytokines  and other stimuli like  
reactive oxygen intermediates   and  lipopolysaccharide  . 
 
As a sequelae to the liver injury , there occurs the alterations in 
composition of   in the extracellular matrix   thus affecting the homeostasis 
of adjacent  cells such as  hepatocytes,   sinusoidal endothelium , Kupffer 
cells  and  thereby  causing stimulation in a paracrine fashion which prime  
the stellate  cells  so as to respond to  cytokines and  growth factors . 
 
 Perpetuation   is the step characterized by the occurrence of cellular 
events which  amplify  the  activated phenotype of Stellate cells   and  
achieving  certain  features that are essentially crucial for the subsequent 
development of  fibrosis. Further  there  occurs  the enhanced proliferation 
of stellate cells , their contractile properties , fibrogenesis , chemotaxis  of  
stellate cells ,secretion of Inflammatory  mediators  and   resulting in the 
altered degradation of extracellular matrix. 
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When the injurious stimuli that  initiated the liver injury  is removed 
as in the case of  Chronic alcoholism   discontinuation of  hepatotoxins  
such as ethanol or  treatment of underlying  liver disease, Stellate cells  
undergo  either  apoptosis  or programmed cell death  or  reverting back  to 
the quiescent  phenotype . 
Proliferation  of  Stellate cell        
 Following the stimulation of stellate cells  , they undergo  
proliferation  rapidly.  The most potent mitogenic factor for Stellate cells is 
Platelet derived growth factor (PDGF -β)  which acts through its 
receptor,β -PDGFR[7] .  
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               Still few   other  inflammators  like vascular endothelial growth 
factor (VEGF), Transforming growth factor - α(TGF - α ), Thrombin ,  
Endothelial growth factor (EGF),    insulin - like growth factor IGF - 1 and 
fibroblast growth factor (FGF)    are implicated  as mitogens for stellate 
cells in the above processes.              
 Acquirement  of  Contractility in Stellate cells   
 After  injury to the liver , the  quiescent stellate cells sooner  acquire 
smooth muscle features leading to the  expression of alpha smooth muscle 
actin [53] and myosin [54] ,  conferring on them with    properties  of 
contractility.   
 
            Considering the  location of stellate cells  in the space of Disse, 
their properties  of  contractility  leading to increase in the   portal 
resistance that can  occur  even with early  stages of  fibrosis .Such an 
increased portal pressure remains reversible than that due to thickened 
septae and distortion of  hepatic lobular architecture occurring in the more 
advanced stages of fibrosis .  
 
The chief  regulators of the  contractility of  stellate cells  are  
Endothelin – 1 ( ET-1 ) and Nitric  oxide (NO )  with mutually opposing 
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actions.   Various  other   factors include  Angiotensin II ,  Atrial Naturetic 
Peptide (ANP ), Eicosanoids,  and  Somatostatin . 
 
Fibrosis 
             Synthesis of type I collagen is the characteristic  feature  of the 
activated  Stellate cells .  TGF - β 1 is  the chief and a powerful  
fibrogenic cytokine for the synthesis of type1 collagen by Stellate  cells  in 
addition to other cytokines like Vascular Endothelial Growth Factor, 
Connective Tissue Growth Factor , and Fibroblast Growth Factor . TGF - 
β 1 is secreted by   endothelial cells  lining the sinusoids,  Hepatic 
Macrophages and Stellate cells  in  both autocrine and paracrine fashion  
thereby leading to fibrosis.    
         
Chemotaxis 
                  Stellate cells migrate to the inflammatory region in response to 
the chemoattractants, like  PDGF [18] , monocyte chemotactic protein - 1 
(MCP -1) and CXCR3 ligands. This migration of the stellate cells  also aid 
in enhancing further interactions with other inflammatory  cells.This 
ability to migrate to sites of injury may also be important  for interactions 
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with the immune system. In addition, there occurs an alteration in the 
between the production and breakdown of matrix  thus resulting in fibrosis  
 
Clinical Features  of HE      
              Development of an acute confusional state with  impaired mental 
status, fetor hepaticus , neuromuscular abnormalities  and hyperventilation 
. The  clinical features  are fluctuating with  varying   from mild confusion 
to deep coma but  abrupt onset  and  developing  over hours to days in 
these patients .  
 
               They   may not exhibit significant neurological symptoms before 
the development of the acute episode except in those who had Persistent 
hepatic encephalopathy . 
 
              The progression of an acute episode tends to parallel the course of 
liver function or the removal of the precipitating factor. Prolonged 
episodes of HE occur among patients with terminal liver failure. 
 
            Patients usually recover from HE without major neurologic deficits 
and are able to return to previous activities. Impairment of consciousness 
initially manifests as subtle changes of personality or disturbances in the 
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circadian rhythm of sleep and wakefulness (i.e., insomnia during the night, 
somnolence during the day).  
 
     As HE progresses, the manifestations include inappropriate behavior, 
disorientation, confusion, slurred speech, stupor, and coma. Some patients 
may experience nausea and vomiting, especially if there is rapid evolution 
into coma.                 
 
            Asterixis is a characteristic feature of HE that represents the failure 
to actively maintain posture or position . Asterixis is caused by abnormal 
function of diencephalic motor centers that regulate the tone of the agonist 
and antagonist muscles normally involved in maintaining posture .  
 
         The classic method of eliciting asterixis is by dorsiflexion of the 
patient's hand, with the arms outstretched and fingers separated. The 
postural lapse that occurs consists of a series of rapid, involuntary, 
flexion–extension movements of the wrist.   
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DIAGNOSIS 
              In a known case of a patient with cirrhosis , bleeding of 
Gastrointestinal Tract presenting with altered sensorium and  Flapping 
tremors on  clinical examination  then it there will be no difficulty in 
diagnosing as a case of  hepatic encephalopathy.  
 
           Sometimes, there may not be the availability of  documents 
regarding the past history and a precipitating event of encephalopathy may 
not be clinically  evident .Therefore the diagnosis may not be arrived at 
earlier and the due therapy is delayed . There is a drawback in diagnosing 
the condition as there is no investigation available at present as a gold 
standard and earmarked as to label the patient as with hepatic 
encephalopathy.  
 
                Availability of fewer individual tests to assess the function of the 
brain  make it a possibility to utilize them as individually and combined to 
get more informations to diagnose the encephalopathy .Such tests available 
as Mental State Assessment  
 NeuroPsychometric tests  
 Neuroimaging modalities   
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 ElectroEncephaloGraphy  and  
 Sensory and Cognitive Evoked Potentials .  
 
Examination  of the Neurological  system  including Mental State  
Assessment  
 
            To   exclude or to  diagnose the presentation of Clinically apparent  
or also called as Overt encephalopathy  following factors are 
considered(35) . 
 
             A) a need for  a carefully taken  and elaborated neuropsychiatric 
history and further aided with examination, with a specific focus on  
mental state changes as concentration, cognition ,  consciousness, memory  
and  quality of life; 
 
B) to  utilize  the  two   systems of grading  to examine  the mental status 
are  
  1) The  West Haven criteria  based on alterations of             
Intellectual   function , behaviour,  consciousness (36)  
         2 ) The GCS -Glasgow Coma Scale.    
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Few more tests are available in the form of   
 Hodkinson Mental State Test, 
 Mini Mental Score Test   
as these tests are used for these patients widely. 
C) a need for a  comprehensively done  neurological examination in 
order to observe  for very subtle motor abnormalities, in the form of 
dysarthria, diminished speed or difficulty in implementing the  rapid and 
also the alternating movements, raised  tone, increased DTR , ataxia , 
impaired postural reflexes and few other abnormal  movements 
manifesting in the form of tremors, specifically as  Flapping Tremors ; 
association of  any localized signs or sensory disturbances features ,then 
we have to look for alternative or other  diagnoses;     
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West Haven Grading of HE 
           
 D) we have to look for and also to exclude the presence of any 
organic causes like subdural haematoma,  intoxication with alcohol  or 
toxicity of drugs , Wernicke ’ s encephalopathy, metabolic abnormalities 
associated with diabetes mellitus  and renal insufficiency or failure. 
           There requires elicitation of history from the patient’s  relatives and 
other friends to correlate the history and to ask for  the   changes noticed in 
the patient’s mental state before the illness. 
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Psychometric Tests              
 Psychometric Tests are used to recognize the Minimal hepatic 
encephalopathy with impairment of psychometric functions in cirrhotic 
patients with clinically stable status . 
              Psychometric tests help us in assessing the severity of the disease 
in the patients with obviously appearing impairment in an objective  
manner . Minimal hepatic encephalopathy alters the psychometric 
functions which are reflected in the Psychometric tests  in the form of  
defective  visuo-spatial abilities, fine motor skills , and attention  when 
compared to  other cognitive capabilities  which are relatively retained . 
                 On the other hand ,  Overt hepatic encephalopathy  reveals few 
more defects in  abilities of concentration  psychomotor speed, and  other 
functions of execution . Over the decades , there were several efforts made 
at simplify and to have a simple yet comprehensive set of tests dependent 
on their ability to detect the alterations in the Psychological and Motor 
functions . It is of practical experience to notice that instead of a single test 
,a battery of investigations are of more helpful in detecting such alterations 
.
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Psychometric tests are also known as Paper and Pencil Tests and 
comprise the following tests employed for these patients .   
 1) Number Connection Test  A              
 2) Number Connection Test B   
          3) Digit Symbol Test (12) 
 4) Serial Dotting Test 
 5) Line Tracing Test 
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 In the above test, results obtained are highly reliable and assuring 
results. In this battery of tests , a type of score called as Psychometric 
Heptaic   Score-PHES is used to assess the parameters like 
visuoconstructive capabilities(12,44)  attention   and  perception  of  
vision. These tests are easily applicable and   where   found  out  to  be  
highly specific for diagnosing hepatic encephalopathy in these patients .
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 Digit  Symbol Test
 
 
Main  disadvantage   of  these  tests is that various confounding 
factors are there and the necessity for their normalization  and from  
among the general  population is required .  At   present, normalized values 
are available only in few European countries like Britain, Spain, Italy and 
Germany. 
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    Serial Dotting  Test       
There are few Psychometric tests  based on Computers  provide us 
an accurate method of estimating the  reaction times and hence yield us 
more precise  assessment .. Other devices include   Scan test which is 
based on the Sternberg paradigm  is helpful in  assessing  those  alterations 
in the cognitive functions and also to detect  subtle defects  in the  memory  
as well as  attention .   
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Tests to assess Neurophysiology  
Electroencephalography (EEG ) 
             The EEG is an investigation which is used to  assess  the  neuronal 
activity of the cerebral cortex .In these patients, with hepatic 
encephalopathy the following findings are   noticed.     
    
1) A progressive slowing of the normal Alpha  Wave frequency            
2) Theta wave shows bursts of slower activity  to begin with seen  in the         
temporal areas, subsequently seen over the entire scalp  
3) Later  , further slowing is noticed in the Delta wave  may then occur.        
4) Arrhythmic Delta Triphasic activity occur in patients  with   higher  
grades .            
5) In coma there occurs   slower  and  delta activity  with lower voltage  
 However,  the above findings as   noticed  in the following 
conditions which can be clinically differentiated include 
encephalopathies due to metabolic causes like hyponatraemia, 
uraemia   
 Drug - induced encephalopathies with the drugs like Valproate, 
Baclofen  and  Lithium  
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There is a varied sensitivity for diagnosing Hepatic Encephalopathy. 
The abnormal EEG is noted in  43%   to 100%patients of  Overt 
Encephlopathy and in  8%  to 40 %of patients with  Cirrhosis and 
remaining clinically stable   
Evoked   potentials 
          On the stimulation of somatosensory nerves carrying auditory, visual  
functions  there  occurs  a generation of potentials with the passive 
perception those sensory stimuli are  called  Exogenous Evoked Potentials.  
               Main advantage of this investigation is its ability  to  asses 
activities of     both brainstem and cortical.  With both minimal and overt 
hepatic   encephalopathies,  there  occurs some   abnormalities of  EPs and 
they indicate the  underlying deranged cortical function but still the results 
obtained are not so consistent as they require to be normalized . 
Endogenous   or cognitive  EPs  :       
 They are evoked by some activity of cognitive functions .A best  
type  of  this type namely P300 is evoked on the perception of  either an 
infrequently delivered   auditory and  visual stimulus interspersed in a 
continuum of otherwise non relevant and recurrent  stimuli.  
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           The evaluation with   P300 latency helps  greatly  in detecting the 
MHE and for following  up. Thus it has a greater diagnostic value 
compared to the other tests.  It cannot be used in higher grades of 
encephalopathy as the technique and method of this test   requires the 
cooperation from the patient . 
Critical flicker fusion frequency (55, 56, 57) 
    Critical Flicker Fusion Frequency (CFF) is a method in which the 
ability to   perceive  a  flickering of light  or  otherwise a fused  light with 
the alterations in its frequency is utilized . 
           It has been detected that 39 Hz is the cut off frequency in 
delineating those patients with Overt encephalopathy  from those with 
stable patients and also delineating  minimal hepatic encephalopathy from 
those cirrhosis yet 
 
   INSTRUMENT FOR MEASURING CFF    
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   HEPATONORM ANALYZER   
   
clinically  stable patients. The sensitivity and specificity of CFF has been 
reported as 55% percentage and 100%   respectively.  
             Several authors have validated the use of Critical Flicker 
Frequency in detecting and further follow up of patients with Minimal 
Hepatic Encephalopathy (68, 69, 70) .  
 
Smooth pursuit eye movements (58) 
        They  are the conjugate movements of the eye by which the eye  
pursues  the moving objects and their recordings in patients with minimal 
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hepatic encephalopathy  reveal  smooth pursuit  movements are affected  
while in patients with overt hepatic encephalopathy those movements are 
either significantly affected or totally  lost .These defects indicate the 
underlying clinical condition  of the patient and alterations in the 
psychometric functions for further monitoring . 
 
Functional and Structural Cerebral imaging 
Various Radiological  investigations  are  available as non invasive 
investigations for the imaging of cerebral structures and its  metabolism .    
 
Cerebral CT and MR imaging  
         1) With routine cerebral CT and MR imaging there occurs  atrophy 
of cerebrum  and cerebellum which does not necessarily  correlate with 
those impairments in  Neuropsychological functions (59,60) .  
Furthermore, cerebral atrophy is not a characteristic abnormality of 
hepatic encephalopathy . 
         2) On MRI T 1 - weighted images,   hyperintensity in the Globus 
Pallidus of  basal ganglia is noticed (60) . It does not correlate with the 
grades of the underlying hepatic encephalopathy.  
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               Manganese has been implicated for the hyperintensities of basal 
ganglia and also features of  Parkinsonism . The concentrations of 
Manganese is raised due to liver failure and the portosystemic shunting of 
prolonged duration. Routine CT  and MRI of Cerebral imaging  does not 
have diagnostic significance in these patients. 
 
Newer  and currently  improved techniques of MRI are more helpful 
like Magnetization transfer and diffusion - weighted imaging assess the 
water content and its distribution in the Cerebrum. Haemodynamic 
responses related to the brain is assessed with the help of Functional MRI 
.With the utilization of  Volumetric MRI , as the name implies  , volumes 
of either as a whole  brain or focused at a specific area of the brain able to 
measure precisely and can monitor even a little difference in the size of the 
brain . 
 
 Cerebral MRS  
                Currently , Proton magnetic resonance spectroscopy is used to  
assess  various  brain metabolites of significance like myoinositol , 
glutamate, glutamine   having their roles in the  development  of hepatic 
encephalopathy.  After getting  released in the metabolism of Ammonia in 
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the Astrocytes  the concentration of glutamine is increased in the  
Cerebrospinal fluid and Cerebral tissues , and tends to parallel the stages of 
hepatic encephalopathy . 
 
                  There occurs a reduction in the brain content of myoinositol  
detected by  Magnetic Resonance  Spectroscopy as a result of raised 
intracellular  osmolality caused by the increased concentration of 
glutamine and as a  compensation .This type of  characteristic changes also 
follows parallel to the severity of impairment of neropsychiatric functions .  
 
             Also it is noticed that  a relative  decrease  in the myoinositol and  
choline resonances  along with a relative increase in the composite 
glutamine/ glutamate resonance indicate  changes in astrocyte volume 
homeostasis. 
 
Levels of Ammonia in the Blood 
When a patient is not presenting as a known case of Cirrhosis along 
with fluctuating sensorium and neurological features ,estimation of blood 
ammonia will  greatly  help in the differential diagnosis of hepatic 
encephalopathy as they may not have  deranged LFT with minimal or no 
symptoms .        
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MATERIALS AND METHODS 
PLACE OF STUDY: 
 This study has been carried out at the General Medicine OP and 
wards, Department of MGE OP and wards at Govt. Stanley hospital, 
Chennai. 
STUDY PERIOD: 
 Six months (From June2013 to November 2013). 
STUDY DESIGN: 
 This is a Prospective Observational Study. 
ETHICAL COMMITTEE APPROVAL:  
 The ethical committee approval was obtained for this study. 
PATIENT SELECTION:                                   
INCLUSION CRITERIA: 
 1)Age more than 18 years and below 70 years 
 2)All patients who have been diagnosed as cirrhosis of the liver and 
detected by clinical, serological, biochemical, assessments and USG. 
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EXCLUSION CRITERIA: 
 1.     Patients aged below 18 years and above 70 years. 
 2.    Patients with overt hepatic encephalopathy  had variceal bleed 
  within 6 weeks. 
 3.    Patients diagnosed as Hepatocellular Carcinoma   
 4.    Patients who had undergone TIPS or shunt surgery.  
 5.    Patients who had taken alcohol in last 6 weeks. 
 6.   Known Patients with cognitive impairment disorders as  
                Alzhiemers disease, Parkinsonism. 
 7.  Patients who are already taking sedatives, antidepressants. 
 8. Patients with impairment of vision .     
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METHODOLOGY 
100 Patients who has been diagnosed as cirrhosis based on clinical, 
biochemical, serological and ultrasonogram visiting in Medicine OP, MGE 
OP and admitted in Medical wards and MGE wards and 50 normal people 
as control group from June 2013 to November 2013 are included in the 
study. Patients will be subjected to symptom analysis, clinical 
examination, laboratory investigations, Psychometric tests and Critical 
Flicker Frequency test to establish the current degree of encephalopathy. 
The final analysis was  made at the end of the study to achieve the  
aforementioned  goals.     
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DISCUSSION 
 
This study includes 150 patients with 100 people as  proven cases of 
Cirrhosis and 50 people as controls for the Psychometric tests . All the 
patients under the study  were found to have no neurological disorder or 
psychiatric illness . 
 
SEX CASES PERCENTAGE CONTROLS PERCENTAGE 
MALE 76 76 % 32 
64 % 
FEMALE 24 24  % 18 
36  % 
TOTAL 100  50  
           
   .  
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 CONTROLS 
 
 
  CASES 
 
There were 76  males and 24 females in the study group .There were 
32 males and 18 females in the control group . In both the grops , the 
predominance of males is seen . 
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 Group N Mean Std. Deviation 
Age in years Control 50 40.38 11.820 
 Study 100 41.03 12.333 
 
Mean age of presentation is 40 years with the youngest being 19 
years  and oldest as 69 years .The mean age of  study group is 41 yrs and  
of controls is 40 years .        
           
           
           
          
 
 
 
 
60 
 
 
Alcoholic 
 INTAKE OF ALCOHOL Frequency Percent 
 Yes 59 59.0 
  No 41 41.0 
  Total 100 100.0 
 
       In  the  study group , only males are consuming alcohol  with no 
females consume alcohol . There are 59 males who are alcoholic among 
the total of 76 males (77 % ) 
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Viral markers 
 
 Frequency Percent 
 Negative 30 30.0 
  HBV + 62 62.0 
  HCV + 7 7.0 
  Wilson’s 1 1.0 
  Total 100 100.0 
 
             There  were 62 patients with Hepatitis B virus positive cases ,7 as 
Hepatitis  C positivity with only one case of proven case of  Wilson’s 
disease . 
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Bilirubin level 
 
Bilirubin 
(mg/dl) Frequency Percent 
1-2 28 28.0 
2-3 32 32.0 
> 3 40 40.0 
Total 100 100.0 
 
 
        
           There were 40 patients with Bilirubin level  more than 3 mg/dl , 32 
cases between 2-3 mg/dl and the rest 28 cases with less than 2 mg/dl . 
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Serum Albumin 
 
 ALBUMIN (mg/dl) Frequency Percent 
 > 3.5 23 23.0 
  2.5-3.5 42 42.0 
  < 2.5 35 35.0 
  Total 100 100.0 
 
 
There were 42 patients with albumin level between 2.5 to 3.5 mg/dl , 
35 patients with less than 2.5 mg/dl and the remaining 23 patients with 
more than 3.5 mg/dl . 
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Ascites 
 
ASCITES Frequency Percent 
 Absent 39 39.0 
  Moderate 30 30.0 
  Severe 31 31.0 
  Total 100 100.0 
 
Ascites was severe in 31 patients,  moderate in 30 patients and no 
ascites in 39 patients .  
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PROTHROMBIN TIME 
 
PT PRLONGATION   
(SEC) Frequency Percent 
 1-4 41 41.0 
  5-6 32 32.0 
  > 6 27 27.0 
  Total 
100 100.0 
 
There was a prolongation of Prothrombin time when compared to 
the control with more than 1 to 4 seconds in 41 patients , more than 5 to 6 
seconds in 32 patients  and more than 6 seconds in 27 patients . 
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CHILD PUGH’S CLASS 
 
CPT CLASS Frequency Percent 
 5-6 29 29.0 
  7-9 40 40.0 
 10-15 31 31.0 
  TOTAL 
100 100.0 
 
 There were 29 patients in CPT Class A,  40 patients in Class B   and 
31  patients in Class C . 
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PSYCHOMETRIC TESTS 
 
 
Group N Mean Std. Deviation 
NCT-A Control 50 57.38 9.243 
  Study 100 85.81 31.746 
NCT-B Control 50 152.34 19.448 
  Study 100 224.07 55.332 
DST Control 50 194.46 34.929 
  Study 100 270.38 49.218 
LTT Control 50 575.60 38.255 
  Study 100 662.62 62.555 
SDT Control 50 207.40 96.533 
  Study 100 271.28 76.997 
CFF (Hz) Control 50 47.882 4.6541 
  Study 100 36.866 3.7761 
CFF(SD) Control 50 1.5770 .74642 
  Study 100 1.2390 .70188 
 
      There exist   significant differences  in the performance of all the 
Psychometric tests as indicated by the values  of median , and standard 
deviation when compared between the study and the control groups 
.(p=0.000) 
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  NCT-A * Group 
 
    
Group 
Total Control Study 
NCT-A Positive Count 0 17 17 
% within 
NCT-A 
.0% 100.0% 100.0% 
% within 
Group 
.0% 17.0% 11.3% 
Negative Count 50 83 133 
% within 
NCT-A 
37.6% 62.4% 100.0% 
% within 
Group 
100.0% 83.0% 88.7% 
Total Count 50 100 150 
% within 
NCT-A 
33.3% 66.7% 100.0% 
% within 
Group 
100.0% 100.0% 100.0% 
Number Connection Test –A was positive in only study group with 
no positivity at all in the control group .  
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 NCT-A Test turned out to be positive in only study group . 
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Group 
Total Control Study 
NCT-B Positive Count 0 60 60 
% within 
NCT-B 
.0% 100.0% 100.0% 
% within 
Group 
.0% 60.0% 40.0% 
Negative Count 50 40 90 
% within 
NCT-B 
55.6% 44.4% 100.0% 
% within 
Group 
100.0% 40.0% 60.0% 
Total Count 50 100 150 
% within 
NCT-B 
33.3% 66.7% 100.0% 
% within 
Group 
100.0% 100.0% 100.0% 
Number Connection Test –B is positive in 60 patients in  the study 
group only . 
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NCT –B was positivity in the study group  only.  
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DIGIT SYMBOL TEST 
 
 
    
Group 
Total Control Study 
DST Positive Count 3 67 70 
% within 
DST 
4.3% 95.7% 100.0% 
% within 
Group 
6.0% 67.0% 46.7% 
Negative Count 47 33 80 
% within 
DST 
58.8% 41.3% 100.0% 
% within 
Group 
94.0% 33.0% 53.3% 
Total Count 50 100 150 
% within 
DST 
33.3% 66.7% 100.0% 
% within 
Group 
100.0% 100.0% 100.0% 
 
There was totally 70 patients showed positivity for Digit 
SymbolTest among which 67 people (95.7 %)were from the study group 
with the remaining 3 people (4.3%) from the control group. 
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Predominantly,  there were more positive people from the study 
group . 
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LINE TRACING TEST (LTT ) 
  
 
    
Group 
Total Control Study 
LTT Positive Count 1 74 75 
% within 
LTT 
1.3% 98.7% 100.0% 
% within 
Group 
2.0% 74.0% 50.0% 
Negative Count 49 26 75 
% within 
LTT 
65.3% 34.7% 100.0% 
% within 
Group 
98.0% 26.0% 50.0% 
Total Count 50 100 150 
% within 
LTT 
33.3% 66.7% 100.0% 
% within 
Group 
100.0% 100.0% 100.0% 
Totally 75 patients were positive for LTT out of which 74 (98.7%) 
people were from the study group.  
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Almost,  Line tracing test was positive in the study group leaving a 
fraction of positivity to the control group .  
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SERIAL DOTTING TEST ( S D T ) 
 
 
    
Group 
Total Control Study 
SDT Positive Count 3 70 73 
% within 
LTT 
4.1% 95.9% 100.0% 
% within 
Group 
6.0% 64.0% 48.7% 
Negative Count 47 30 77 
% within 
LTT 
61.1% 38.9% 100.0% 
% within 
Group 
94.0% 30% 51.3% 
Total Count 50 100 150 
% within 
LTT 
33.3% 66.7% 100.0% 
% within 
Group 
100.0% 100.0% 100.0% 
 
There were totally 73 people showed positivity for Serial Dotting 
Test out of which 70   people (95.9%) were from the study group while the 
remaining 3 people (4.1%) were from the control group.  
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CRITICAL FLICKER FREQUENCY (CFF) 
 
     
Group 
Total Control Study 
CFF (Hz) Positive         
(<39Hz) 
Count 4 73 77 
% within 
CFF (Hz) 5.2% 94.8% 100.0% 
% within 
Group 
8.0% 73.0% 51.3% 
Negative 
(>39Hz)              
Count 46 27 73 
% within 
CFF (Hz) 63.0% 37.0% 100.0% 
% within 
Group 
92.0% 27.0% 48.7% 
Total Count 50 100 150 
% within 
CFF (Hz) 33.3% 66.7% 100.0% 
% within 
Group 
100.0% 100.0% 100.0% 
 
 There were 73 patients (94.8%) who turned out to be positive 
among the study  group  and 4 patients  (5.2%)from the control group were 
positive in Critical Flicker Frequency Test . (p value =0.000) 
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 Critical Flicker Frequency Test was more positive in the study group 
than the control group.  Only a few positivity is noted among the control 
group.  
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SUMMARY 
 
 In our study , 100 patients who have been diagnosed and proven as a 
case of cirrhosis were include under the study group and 50 other 
people were included as control group without any evidence of liver 
disease .Before the study was commenced , all the people in both 
group were clinically examined  and were ruled out of any 
neuropsychological abnormalities .We utilized the Psychometric 
tests in the study group and compared with the age , sex  and 
education wise matched .In addition ,Critical Flicker Frequency Test 
was carried out in both the study group and the results were 
compared for further analysis . 
 
 In our study, there was a preponderance of males in both the study 
groups with 76 males in the study group comprising 76% and 32 
males in the control group as 64% of the members in their groups .   
 
 
 Mean age of presentation is 40 years with the youngest being 
19years  and oldest as  69 years .The mean age of the  study group is 
41 yrs while  that of  the controls is 40 years .   
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 Regarding the consumption of alcohol,   in  the  study group , only 
males are consuming alcohol  with totally  no females consume 
alcohol . There are 59 males who are alcoholic among the total of 76 
males (77 %) in the study group.  
 
 Among the 100 patients in the study group Hepatitis B virus is the 
causative agent of cirrhosis in 62 patients  comprising majority of 
the study group with 62%  while 7 patients have been affected by 
Hepatitis  C virus constituting  only 7%  and with only one case of 
Wilson’s disease (1%) .In the remaining, Alcohol is the main 
causative factor constituting 30% in the study group . 
 
 In our study, 40 patients had Bilirubin values more than 3 mg/dl   
while 32 patients with values between 2 to 3 mg/dl.  
 
 Albumin levels in the patients of between 2.5 to 3.5 mg/dl were 42 
in number (42%) while 35 patients had low levels of Albumin of 
less than 2.5 mg/dl.  
 
 Ascites was moderate in 30 patients and severe in 31 patients while 
39 people were free of ascites at the time of the study.  
 
 Prothrombin time was prolonge compared to the control value by 
6seconds in 27 patients and by 5 to 6 seconds in 32 patients . 
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 Majority of the patients in our study fell under Child Pugh’s Classes 
B as 40 patients and 31 patients under Class C.   
    
 Performances of the Psychometric tests among the study group and 
the control group yielded  significant results among the study group . 
(p=0.000) 
 
 Critical Flicker Frequency Test was more positive in the study group 
then the control group and was found to be statistically significant 
values obtained as 0.000 indicating the higher significance when 
compared with the controls. 
 
 Both the Psychometric tests and Critical Flicker Frequency Test 
were useful in detecting cases of Minimal Hepatic Encephalopathy.  
 
 Critical Flicker Frequency Test was found to be more positive 
among the study group with 73% than the control group and hence 
the ability to detect the cases of Minimal hepatic encephalopathy 
than the Psychometric tests.  
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CONCLUSION 
Our study demonstrated the occurrence of Minimal Hepatic  
Encephalopathy (MHE) in patients with Cirrhosis irrespective of the 
etiology even in the presence of stable clinical condition . Both Critical 
Flicker Frequency (CFF) Test and Psychometric tests have been found out 
to be effective in detecting MHE . Psychometric tests have subjective 
variations due to their  age  factor , differences in education  while CFF 
Test has no such limitations and more  of objective in nature not requiring 
any educational qualification for undergoing and interpretation of the light 
stimulus and is reproducible .The  detection of  MHE in more numbers in  
our study may be due to higher number of  patients with higher classes of 
Child Pugh classification .The presence of  majority of the patients with 
Hepatitis B infection is due to our place of study being a tertiary care and a 
prestigious institute of Gastroenterology .   
Hence, we would like to recommend the utilization of Critical 
Flicker Frequency (CFF) Test as an Out Patient Department  based 
screening procedure and also for the monitoring of  patients with cirrhosis 
yet with  a stable clinical condition so as to detect MHE earlier and 
promptly institute the therapy to avoid the  complications .    
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PROFORMA 
 NAME :  
SL. NO :  
AGE / SEX :          
OCCUPATION:         
ADDRESS WITH CONTACT NUMBER:       
IP NO:           
DATE OF ADMISSION:        
DATE OF DISCHARGE/ DEATH:  
HISTORY: 
H/O JAUNDICE 
H/O MALENA 
H/O HEMETEMESIS 
H/O BLOOD TRANSFUSION 
H/O ANY ENDOSCOPIC INTERVENTION 
H/O BLEEDING FROM ANY OTHER SITES 
H/O ALTERED SLEEP PATTERN                                                               
H/O ANY ALTERED  SENSORIUM  
H/O  CONVULSION 
H/O ALCOHOL INGESTION  
Physical examination 
Sensorium  
Pallor 
Icterus 
Pedal edema 
BP:                          PR: 
CVS - 
RS - 
P/A -  
CNS –FLAPS  +/- 
INVESTIGATIONS 
CBC –  TC 
DC 
ESR 
HB 
PLATELETS 
BLOOD SUGAR 
UREA 
SERUM CREATININE 
SODIUM 
POTASSIUM 
CHLORIDE 
BICARBONATE  
LFT-    TOTAL BILIRUBIN 
             DIRECT BILIRUBIN 
INDIRECT BILIRUBIN 
SGOT 
SGPT 
SAP 
TOTAL PROTEINS 
ALBUMIN 
PT 
APTT 
INR 
VIRAL MARKERS                         
ULTRASONOGRAM OF ABDOMEN                                         
       
URINE EXAMINATION 
ECG      
  
PSYCHOMETRIC TESTS            
NUMBER CONNECTION TEST A-          
NUMBER CONNECTION TEST B-          
DIGIT SYMBOL TEST         
LINE TRACING TEST         
SERIAL DOT TEST                 
CRITICAL FLICKER FREQUENCY TEST                                                                                      
 
 
  
LINE TRACING TEST   
 
 
  
SERIAL DOTTING TEST 
 
 
  
CONSENT FORM
 
 
 
 
 
  
ETHICAL COMMITTEE APPROVAL LETTER  
 
 
  
  
                                KEY TO MASTER CHARTS 
   
Bilirubin 1=1-2mg/dl                      2=2-3mg/dl 
Ascites 1-Absent                         2-Moderate             3-Severe 
Albumin 1=>3.5mg/dl                    2=3to3.5mg/dl       3=<3.0mg/dl 
Prothrombin 
time (PT) in sec 
1=1-4sec                          2=4-6sec                    3=>6sec 
Child Pugh’s 
class  (CPT) 
1=5,6                              2=7,8,9                        3= 10 to 15 
NCT-A  NCT-B Number Connection Test –A , Number Connection Test -B 
DST Digit Symbol Test  
LTT Line Tracing Test  
SDT Serial Dotting Test  
 
  
ABBREVIATIONS 
ACh   –  Acetyl Choline  
BBB   –  Blood Brain Barrier 
DST   –  Digit Symbol Test  
EEG   - Electroencephalogram 
GABA - Gamma amino butyric acid 
GCS  -  Glasscow Coma Scale    
HE   –  Hepatic Encephalopathy 
LFT   –  Liver Function Test 
LTT  -  Line Tracing Test  
MHE   –  Minimal Hepatic Encephalopathy 
NCT   -   Number Connection Test 
PT  -  Prothrombin time 
SDT   –  Serial Dotting Test 
USG   - Ultrasonogram 



 
MASTER CHART - CASES 
SEX Age Hb 
gm% 
Urea Creat Bilirub  
Album 
Ascites PT CPT 
CLASS 
Alcoholic Viral mar NCT-
A 
NCT-
B 
DST LTT SDT CFF 
(Hz) 
CFF(SD) 
M 32 10.6 26 0.6 1 1 1 1 1 YES NEGATIVE  49 154 195 565 235 36.2 1.16 
M 38 9.2 22 0.5 2 2 1 1 1 YES NEGATIVE  50 166 206 675 79 46.6 2.1 
M 68 10.2 30 1.1 3 3 3 3 3 YES NEGATIVE  52 268 278 630 105 33.2 1.7 
F 42 9.6 29 1 1 1 1 2 1 NO NEGATIVE  48 152 236 645 125 31.4 1.05 
F 42 9.1 26 8 1 2 1 2 1 NO NEGATIVE  62 174 240 548 69 36.2 1.17 
M 52 10.8 30 5 2 2 2 2 2 YES NEGATIVE  54 162 192 622 275 35.1 1.7 
F 37 10.2 28 1.1 4 3 3 3 3 NO NEGATIVE  95 290 339 698 280 37 1.33 
M 68 10.4 35 1 2 2 2 1 2 YES NEGATIVE  58 168 186 720 295 30.9 1.61 
M 56 9.8 33 0.7 1 1 1 2 1 YES NEGATIVE  56 210 265 735 305 34.6 1.68 
M 36 11.2 29 0.8 2 2 2 1 2 YES NEGATIVE  95 242 275 536 235 32.4 1.11 
M 69 9 37 1.2 3 3 3 3 3 YES NEGATIVE  101 196 286 715 318 37.3 1.3 
F 39 8.6 22 0.6 2 2 1 2 2 NO HBV + 55 206 308 692 345 33.3 1.22 
M 41 10.3 30 0.5 1 1 1 1 1 NO HBV + 58 161 239 680 285 35.8 1.08 
M 48 12 35 0.7 3 3 3 3 3 YES HBV + 115 302 315 705 297 38.3 0.65 
M 30 12.3 19 0.6 2 3 3 3 3 YES HBV + 60 196 329 568 108 41.1 1.37 
M 37 11.3 21 0.4 3 3 3 3 3 YES HBV + 57 245 262 720 75 36.2 1.62 
M 31 11.1 26 0.6 1 1 1 2 1 YES HBV + 65 286 285 650 280 38.5 1.43 
M 30 12.6 27 0.8 3 3 2 1 2 YES HCV+ 125 174 295 748 273 35.5 0.9 
F 30 9.2 19 0.4 2 2 2 1 2 NO HBV + 139 156 195 540 125 39.9 0.63 
M 39 11.6 20 0.5 3 3 3 3 3 YES HBV + 95 306 340 692 314 36.3 2.43 
M 37 11.8 32 0.8 1 1 2 1 1 YES HBV + 82 165 186 635 335 42.4 1.52 
M 20 12.4 19 0.4 2 2 2 2 2 YES HBV + 139 194 255 672 345 34.6 1.12 
M 29 10.9 21 0.5 3 3 2 1 2 YES HBV + 105 152 205 550 632 36.6 1.53 
M 53 10.4 31 0.6 3 3 3 3 3 YES HBV + 98 275 276 708 260 34.7 0.72 
F 30 9.6 22 0.8 1 1 1 2 1 NO HBV + 48 275 286 740 345 35.6 1.04 
M 30 12.2 24 0.8 2 2 2 1 2 NO HBV + 95 246 306 635 296 34 0.84 
M 37 11.4 35 0.5 3 3 3 3 3 NO HBV + 109 196 236 679 306 37.9 0.57 
M 54 9.8 38 0.9 1 2 1 2 1 YES HBV + 56 302 317 526 283 32.4 1.63 
M 40 11 27 0.8 2 2 1 2 2 YES HBV + 45 262 325 732 295 34.6 1.31 
M 26 12.1 21 0.6 3 3 3 3 3 YES HBV + 135 193 203 638 306 34 2.35 
M 49 11.6 37 0.8 1 2 1 2 1 YES HBV + 58 306 337 706 345 34.3 1.12 
M 37 10.4 19 0.5 3 3 3 3 3 YES HBV + 94 246 339 639 329 34.7 1.77 
M 33 12.4 21 0.6 2 2 2 1 2 NO HBV + 118 174 180 585 235 41.7 0.99 
M 51 11.8 32 1 3 3 3 3 3 NO NEGATIVE  140 305 252 710 292 36.5 1 
M 38 9.8 25 0.8 1 1 1 2 1 NO NEGATIVE  48 198 279 692 308 35.9 1.49 
M 40 10.2 31 0.9 2 2 2 1 2 YES NEGATIVE  138 286 251 572 210 37.9 0.41 
M 33 11 29 0.8 3 3 2 1 2 YES NEGATIVE  116 176 190 687 312 33.7 1.97 
F 55 9 34 0.9 1 1 1 2 1 NO NEGATIVE  51 254 306 725 285 37 2.31 
F 50 9.6 32 1 2 2 2 1 2 NO NEGATIVE  135 163 203 692 313 35.5 1.28 
M 27 11.8 28 0.5 3 3 3 3 3 YES NEGATIVE  106 236 318 585 178 41.3 0.78 
M 61 10.6 38 1.2 1 1 1 2 1 YES HCV+ 88 278 329 710 348 36.4 1.24 
M 53 11 34 0.9 2 2 1 1 1 YES NEGATIVE  60 175 239 720 254 36.7 0.86 
M 53 9.6 31 1 3 3 3 3 3 NO NEGATIVE  117 304 330 684 336 33.8 1.41 
F 45 8.6 33 0.7 1 1 1 2 1 NO NEGATIVE  54 218 335 695 275 34.7 1 
F 19 10.2 29 0.5 3 3 3 1 3 NO WILSON'S 105 168 216 594 210 49.3 5.33 
M 62 10.8 39 1.1 2 2 1 2 2 YES NEGATIVE  56 230 265 736 280 33.3 1.21 
M 45 11.4 29 0.9 1 1 1 2 1 NO NEGATIVE  47 264 302 736 326 35.5 1.56 
F 32 9.6 24 0.6 3 3 3 3 3 NO NEGATIVE  104 295 295 675 315 36 0.97 
M 50 11.6 31 0.7 2 2 1 2 2 YES HBV+ 51 304 316 605 228 39.9 1.02 
M 28 11.2 24 0.6 1 2 1 2 2 NO HBV+ 58 248 340 639 260 36.2 1.39 
M 23 12.6 25 0.6 3 3 3 3 3 YES HBV+ 99 286 295 740 322 41.6 0.63 
M 63 9.4 37 1.1 2 2 2 1 2 YES HBV+ 96 172 195 705 250 31.2 2.55 
M 20 13.4 18 0.7 1 1 1 2 1 NO HBV+ 46 298 268 659 329 42.2 0.33 
M 68 11 36 1.2 2 2 2 1 2 YES HBV+ 107 179 204 572 165 36.9 0.67 
M 27 12.6 20 0.7 3 3 3 3 3 YES HBV+ 100 302 296 730 340 33.8 1.86 
M 40 10.8 24 0.9 1 1 1 1 1 YES HBV+ 60 180 306 670 282 40.8 2.13 
M 60 12 32 1 2 2 1 2 2 NO HBV+ 109 196 316 604 206 36.2 0.52 
F 60 10.6 36 1.2 3 3 3 3 3 NO HCV+ 114 267 325 737 259 34.7 1.18 
F 25 10.8 19 0.8 1 1 1 1 1 NO HBV+ 54 156 237 605 176 40.8 1.81 
M 23 12.4 21 0.9 3 2 2 1 2 YES HBV+ 109 173 340 692 286 32.4 1.32 
M 56 11.6 33 0.8 3 2 1 2 2 YES HBV+ 51 302 257 648 254 38.8 0.79 
M 19 14.6 18 0.6 1 2 1 2 2 YES HBV+ 49 197 229 706 263 40.3 2.04 
M 46 11.4 25 0.8 3 3 3 3 3 YES HBV+ 130 275 306 528 186 37 0.51 
F 48 9.2 24 0.7 2 2 2 1 2 NO HBV+ 109 154 218 720 309 40.6 0.96 
M 36 11.6 27 0.6 1 1 1 2 1 YES HBV+ 57 264 338 685 318 36.6 1.29 
M 42 11 30 0.9 2 2 2 1 2 YES HBV+ 150 180 186 565 146 31 1.39 
F 29 9.4 34 0.5 3 3 3 3 3 NO HBV+ 135 286 259 725 330 29.3 1.23 
M 46 11.2 31 0.6 1 1 1 2 1 NO HCV+ 60 245 315 697 257 39.1 0.45 
F 52 8.9 38 0.8 3 3 3 3 3 NO HBV+ 98 278 256 542 132 42.5 0.37 
M 37 13.2 19 0.9 2 2 1 2 2 YES HBV+ 61 236 306 620 278 38.8 0.56 
M 41 12.4 21 0.8 2 2 2 1 2 YES HBV+ 107 157 236 685 306 44.8 2.03 
M 31 12.6 18 0.7 1 1 1 1 1 YES HBV+ 67 176 206 715 286 40.8 0.86 
M 61 10.2 38 1.1 3 2 2 1 2 NO HBV+ 108 162 229 608 186 31.1 0.7 
M 41 11.8 27 0.5 3 3 3 2 3 YES HBV+ 139 297 282 739 305 36.6 0.32 
M 46 12.6 28 0.8 1 1 1 1 1 NO HCV+ 59 180 296 730 329 39.8 0.55 
M 33 12 24 0.6 2 2 2 2 2 YES HBV+ 137 305 287 526 215 41.3 0.93 
M 60 9.4 35 1.1 3 3 3 3 3 NO HBV+ 125 278 259 685 268 31.3 1.53 
M 49 10.6 30 0.9 1 1 1 1 1 YES HBV+ 52 153 312 638 276 33.5 1.63 
M 50 9.8 36 1 2 2 1 1 1 YES HBV+ 61 164 329 695 286 35.9 0.58 
M 55 11.2 35 1.1 1 1 1 1 1 YES HBV+ 57 151 185 609 238 35.5 1.39 
M 40 11 28 0.6 3 3 3 3 3 YES HBV+ 135 235 339 720 308 35.2 0.44 
M 40 12.1 24 0.5 2 2 2 2 2 YES HBV+ 54 285 278 725 345 45.1 1 
M 41 13 19 0.8 3 3 3 1 3 YES HCV+ 138 178 295 628 295 42.6 0.81 
F 31 9.2 18 0.7 1 1 1 3 1 NO HBV+ 48 302 286 648 307 38.9 0.73 
F 42 9.8 28 0.9 3 3 2 1 2 NO HBV+ 62 169 196 582 210 38.5 0.84 
F 55 9 34 1 2 2 2 1 2 NO HBV+ 68 172 256 740 328 36.3 0.49 
F 23 9.3 19 0.6 3 3 3 2 3 NO HBV+ 130 262 305 705 286 41.6 1.03 
M 47 13 25 0.5 2 2 2 1 2 YES HCV+ 70 179 182 670 316 33.2 2.4 
M 35 12.4 18 0.5 3 2 2 2 2 NO HBV+ 81 295 239 700 325 39.2 2.84 
M 42 11.6 31 0.6 3 2 2 1 2 YES HBV+ 83 153 235 596 228 37.9 0.83 
F 36 9.3 21 0.6 3 3 3 3 3 NO HBV+ 109 264 335 685 350 30.4 2.52 
F 41 8.4 25 0.7 2 2 1 3 2 NO HBV+ 51 236 269 705 327 34.4 0.57 
F 31 9.6 19 0.8 3 3 3 3 3 NO HBV+ 118 285 289 680 250 33.9 0.65 
M 43 12.2 23 0.9 1 1 1 1 1 YES HBV+ 58 180 240 603 297 35.7 1.29 
M 35 11.4 20 0.6 2 2 2 1 2 NO NEGATIVE  71 173 306 692 296 36.9 1.22 
F 22 9.6 18 0.5 3 3 3 1 3 NO NEGATIVE  120 305 326 735 345 39.9 0.65 
M 32 11.4 19 0.6 2 2 1 2 2 YES NEGATIVE  76 292 286 740 260 39.1 0.6 
M  20 11.8 18 0.5 2 2 2 1 2 YES NEGATIVE  61 150 305 620 337 29.3 0.35 
M 40 10.2 24 0.8 3 3 3 1 3 YES NEGATIVE  128 161 186 583 162 37.6 1.62 
M 38 11.6 22 0.9 3 2 2 1 2 YES NEGATIVE  69 180 329 739 308 42.8 0.93 
 
  
MASTER CHART -CONTROLS 
SEX AGE NCT-A NCT-B DST  LTT SDT CFF (Hz) CFF(SD) 
M 32 56 129 180 525 206 52.6 1.2 
M 38 60 136 175 539 148 50.1 0.64 
F 42 46 175 215 540 235 46.2 0.76 
M 64 54 179 210 532 175 46.2 1.24 
M 52 50 165 145 605 162 38.2 1.2 
F 43 55 125 240 635 182 41.2 0.64 
F 37 78 165 145 582 192 45.6 2.14 
M 56 60 136 156 575 235 48.2 1.76 
M 36 86 145 168 602 140 50.2 0.74 
M 69 56 156 172 608 158 53.9 0.82 
M 39 74 176 192 582 162 44.2 0.46 
F 27 48 125 205 610 185 46.8 0.7 
M 30 50 135 238 589 196 47.2 1.9 
M 37 56 140 150 537 210 39.2 1.43 
M 31 64 152 171 558 235 53.8 0.63 
F 30 58 165 176 542 240 51.2 0.52 
M 39 53 176 182 564 146 45.3 1.68 
F 20 60 179 206 575 178 48.2 2.34 
M 29 58 129 235 582 196 51.2 1.9 
F 50 52 134 182 536 185 38.2 1.87 
 M 22 78 142 202 594 840 53.9 1.44 
F 38 48 149 260 702 215 45.2 0.66 
F 54 54 172 235 535 183 38.9 1.42 
M 40 60 165 220 560 216 49.2 2.8 
M 26 56 154 152 601 239 51.2 1.6 
M 49 54 138 164 609 168 53.4 1.9 
F 30 66 167 168 521 182 45.2 1.46 
F 38 48 157 172 562 196 50.1 0.86 
M 51 52 178 185 549 208 52.6 0.62 
F 38 57 159 205 610 231 46.4 1.6 
F 40 58 180 201 539 152 44.6 1.21 
M 33 56 120 150 581 159 48.1 1.96 
F 55 74 127 159 590 230 46.9 2.9 
F 51 51 132 168 606 219 37.2 1.61 
M 38 49 167 172 529 149 51.6 0.62 
M 42 56 158 195 531 230 53.4 0.94 
M 33 52 121 228 576 151 45.3 1.72 
F 55 48 138 276 571 226 47.2 1.48 
M 50 57 145 146 523 238 46.1 0.69 
F 27 54 165 157 582 168 41.2 2.86 
F 61 56 179 235 596 192 51.3 1.74 
M 53 51 172 172 528 228 53.9 0.63 
M 45 50 165 210 592 152 46.2 3.24 
F 55 58 132 181 535 235 53.4 0.97 
F 19 54 127 217 568 182 52.4 1.92 
M 45 84 134 284 680 235 51.6 0.73 
F 47 59 180 210 587 168 46.2 1.76 
F 32 49 172 235 608 205 48.2 0.84 
 M 28 50 129 182 592 168 52.3 3.16 
F 23 56 171 239 605 239 53.2 1.94 
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